来自MSN1 天
Bone Mineral Density Deficits Prevalent Among Childhood Cancer Survivors
Survivors of childhood cancer face challenges from bone mineral density (BMD) deficits due to treatment exposures and other ...
Hyderabad hospital's tech leap in faster cancer treatment with advanced proton therapy system
The system is based on novel technology that promises to simplify treatment and delivery and increase the number of patients ...
Cure Today2 天
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Rolling Out5 天
How blood disorders can lead to blood cancers
Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes ...
GlobalData on MSN4 天
FDA awards GSA breakthrough status for relapsed osteosarcoma treatment
GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted ...
ascopubs.org5 天
Expanding the Horizon of MRONJ Research in Breast Cancer Bone Metastasis Treatments
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Onlymyhealth2 天
What Is Acute Lymphoblastic Leukaemia: Exploring Its Symptoms, Survival Rate, Life ...
Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share ...